Making radiotherapy more effective against cancers that have spread to the brain
- Researcher: Dr Manuel Valiente
- Institution: Spanish National Cancer Research Centre (CNIO), Madrid, Spain
- Award Amount: £151,887 for 3 years from 1st January 2019
- Cancer Type: Breast Cancer, Lung Cancer
Dr Manuel Valiente and his team based at the National Cancer Research Centre, Madrid, Spain, have recently discovered that a specific protein found in cancers that have spread to the brain seems to be linked to the cancer being resistant to radiotherapy. Dr Valiente now wants to study this link in more detail to find out how this protein controls resistance to radiotherapy and its role in the spread of cancer to the brain. Ultimately, they want to work out if this protein can be used as a marker to identify patients that will benefit from radiotherapy, and see if they can target the protein therapeutically to make radiotherapy more effective.
The Research That Is Happening Right Now
Explore current projects to see how far-reaching our research is from a global perspective.
See the difference our research projects make.